1400 Wewatta Street Suite 600, Denver, CO USA 80202
701 Pennsylvania Avenue, NW Suite 200, Washington, DC USA 20004
Justin Krieger serves as the Managing Partner of the firm's Denver office. He is a first chair inter partes review (IPR) and post-grant review (PGR) litigator with an over 90% win rate in both challenging third party patents and defending against patent challenges brought before the Patent Trial & Appeal Board (PTAB). He also serves as an adjunct Professor of Law at the University of Denver Sturm College of Law where he teaches a course on PTAB studies. As a registered patent attorney, Mr. Krieger also focuses on district court and ITC litigation, client counseling, and patent prosecution. His technical focus includes chemistry, chemical engineering, biotechnology, medical devices, metallurgy, nanotechnology, mechanical engineering and consumer products. He has significant experience managing large domestic and international patent portfolios in these industries.
Mr. Krieger lectures and publishes frequently on various intellectual property topics, including the America Invents Act, the “on sale” bar to patentability, IPR and PGR proceedings, best practices in drafting patent applications and the Defend Trade Secrets Act of 2016.
Mr. Krieger was was recognized in 2024 by The Best Lawyers in America® for Patent Law. He was recommended by Legal 500 US in 2018, 2020, 2021 and 2024 for Patent Prosecution. Mr. Krieger was named a top national patent practitioner in 2024 and the six years immediately preceding by IAM Patent 1000 – The World's Leading Patent Practitioners. He was recognized as an “IP Star” in 2022 and 2023 by Managing Intellectual Property magazine. In 2021, Mr. Krieger was listed in Barrister's Best and selected as the “People’s Choice” Best IP Litigator by Law Week Colorado.
While attending law school, Mr. Krieger was a member of the Florida Law Review.
Experience
Mr. Krieger supervises a post-grant patent practice team that has consistently obtained favorable results for the firm’s clients. He has served as lead counsel in well over 20 IPR and PGR proceedings, representing clients both as petitioner and patent owner. Mr. Krieger has repeatedly beaten the odds: representing Patent Owners, he successfully achieved denial of institution in 8 IPRs, and won 5 IPRs after trial. All five cases going to trial resulted in the validation of all instituted claims—a result achieved in fewer than 5% of IPR proceedings. Representing client TerraLithium LLC, in 2020-2021, Mr. Krieger achieved complete victories in 7 IPRs, with institution denied or all patent claims affirmed after trial for all 7 different patents.
Representing Petitioners, Mr. Krieger has been equally successful: In 2017, Mr. Krieger successfully represented Petitioner in two IPRs, resulting in the Patent Owner requesting adverse judgment. In 2018, Mr. Krieger successfully took three IPRs to trial on behalf of Petitioner. In 2019, he achieved another win as IPR petitioner, resulting in an early grant of a client’s motion to terminate the proceeding on terms highly favorable for the client.
Mr. Krieger also actively prepares non-infringement and validity opinions including comprehensive freedom-to-operate (FTO) analyses in the chemical, polymer, medical device, and mechanical arts from both due diligence and litigation perspectives. Mr. Krieger also has been actively involved in numerous patent litigation matters and has participated in all phases of discovery, claim construction (Markman hearings), trial, and appeals. He is also experienced in Section 337 investigations before the U.S. International Trade Commission (ITC).
Mr. Krieger leads a patent prosecution team for clients in the fields of industrial chemistry and chemical engineering, pharmaceuticals, agrochemicals, medical devices and analytical instruments.
Insights View All
News Releases
Blogs
Adversarial Patent Prosecution℠
Asset Creation - Prosecution & Counseling
Licensing, Transactions & Monetization
Chemicals: Industrial Chemistry & Materials and Material Science
Life Sciences: Biotechnology, Pharmaceuticals & Bioinformatics
University of Florida College of Law J.D. (1999)
College of William and Mary B.S. (1995) Chemistry
Colorado (2018)
District of Columbia (2002)
New York (2000)
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the District of Columbia
U.S. District Court for the Eastern District of Virginia
U.S. Patent and Trademark Office
U.S. Supreme Court
University of Denver Sturm College of Law, Adjunct Professor of Law, PTAB Practice
Board Member, Colorado IP American Inn of Court
Law360, Colorado Editorial Advisory Board (2024)
Chair, American Chemical Society (ACS) Committee on Patents and Related Matters
Board of Trustees, ACS Division of Chemical Education (2020-2022)
PTAB Bar Association
Federal Circuit Bar Association (member, PTAB & TTAB Committee)
American Bar Association
American Intellectual Property Law Association
Intellectual Property Owners Association
ITC Trial Lawyers Association
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.
